SEC Filing Summary: Charles River Laboratories International, Inc.
Business Context and Reporting Period
This Form 8-K, filed on August 6, 2025, reports the results of operations for the second quarter ended June 28, 2025. The filing serves as a current report to disseminate financial results announced via a press release attached as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the body of the 8-K. Investors must refer to the attached press release for comparative financial analysis.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The filing notes that the attached press release contains forward-looking statements protected by the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.
- Risks: The document states that risks relating to the company are set forth in other documents filed with the SEC, rather than listing them directly in this report.
- Unusual Items: No unusual items or contingencies are described in the text of this specific filing.
Key Facts for Investor Verification
- Verify the specific revenue and earnings figures in the attached press release (Exhibit 99.1) as they are not present in the 8-K text.
- Review the "safe harbor" language in the press release to understand the assumptions behind forward-looking guidance.
- Consult the company's most recent 10-K or 10-Q filings for a comprehensive list of risk factors referenced in this report.
- Confirm the exact quarter end date of June 28, 2025, for accurate period-over-period comparisons.